pembrolizumab
merck,astrazeneca
['keytruda', 'astrazeneca', '$mrk', '$azn']
$azn $mrk esmo: astrazeneca's checkpoint inhibitor bispecific may rival keytruda, but dose change leaves questions 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities